Search

Heron Therapeutics Inc

Lezárt

SzektorEgészségügy

0.47 2.17

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

0.46

Maximum

0.48

Fő mutatók

By Trading Economics

Bevétel

-5.2M

-8.1M

Értékesítés

-5.9M

35M

Egy részvényre jutó nyereség

-0.04

Profit margin

-23.367

Munkavállalók

128

EBITDA

-6.8M

-7.6M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+316.67% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. aug. 7.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-152M

78M

Előző nyitás

-1.7

Előző zárás

0.47

Hangulat hírek alapján

By Acuity

67%

33%

285 / 340 Rangsor szerint Healthcare

Heron Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. júl. 20. 23:56 UTC

News

Brookdale Senior Living announced its second-quarter 2026 earnings release dates, boosting investor sentiment. Shares are trading higher in after-market hours.

2026. júl. 20. 23:56 UTC

News

Valero Energy Corp gains in after-market trading on strong earnings forecast, with projected EPS of $9.81 and revenue expectations of $35.95 billion.

2026. júl. 20. 23:51 UTC

News
Correlated Moves

Ally Financial shares are lower in after-market trading despite the board declaring a quarterly cash dividend of $0.30 per share.

2026. júl. 20. 23:51 UTC

Social Media
News

Magnolia Oil & Gas announced a $1 billion stock offering to fund the acquisition of WildFire Intermediate Holdings, resulting in a sharp decline in after-market hours.

2026. júl. 20. 23:46 UTC

News

Advanced Energy Industries gained after-market hours following $31 million in funding for the Idaho Advanced Energy Consortium's Nuclear Energy Corridor Tech Hub initiative.

2026. júl. 20. 23:46 UTC

News

Ross Stores announced 47 new locations but shares are trading lower in after-market hours following Monday's close. The company plans to open about 110 stores in 2026.

2026. júl. 20. 23:46 UTC

News

Monarch Casino & Resort Inc reports record Q2 revenue of $142.6 million and EPS of $1.78, trading higher in after-market hours.

2026. júl. 20. 23:46 UTC

News

Sweetgreen Inc shares are higher in after-market trading, despite ongoing concerns in the restaurant sector over a cyclospora outbreak linked to iceberg lettuce.

2026. júl. 20. 23:46 UTC

News

Warner Bros Discovery shares are lower in after-market hours as a judge pauses the $110 billion Paramount Skydance acquisition, extending legal uncertainty.

2026. júl. 20. 23:41 UTC

News
Event

Calix Inc's stock is lower in after-market trading following a mixed earnings report and a disappointing third-quarter outlook, alongside a class action lawsuit.

2026. júl. 20. 23:36 UTC

News

GameStop shares are lower in after-market hours as the company proposes a stock-based acquisition of eBay, introducing significant new debt and operational changes.

2026. júl. 20. 23:36 UTC

News
Correlated Moves

Invesco Ltd's shares rose during after-market hours, reflecting a modest increase since Monday's close, alongside gains in the Invesco S&P 500 High Dividend Low Volatility ETF.

2026. júl. 20. 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

2026. júl. 20. 23:32 UTC

News

Broadcom Inc. shares are higher in after-hours trading, driven by strong historical returns and potential growth from Meta Platforms' AI chip production plans.

2026. júl. 20. 23:26 UTC

News
Correlated Moves

Blackstone Inc. shares are higher in after-market trading following a $676 million investment in South Korea's Futronic, enhancing its technology portfolio.

2026. júl. 20. 23:16 UTC

News

Enphase Energy shares fell after TD Cowen cut its price target from $70 to $48, citing a challenging solar market and weaker demand. The stock was roughly flat in after-market trading.

2026. júl. 20. 23:16 UTC

News
Social Media

Alphabet Inc shares are higher in after-market hours as reports reveal plans for a new AI chip that may significantly outperform current models.

2026. júl. 20. 23:16 UTC

News

Quanta Services reported a $48 billion backlog, signaling strong revenue potential. Shares moved higher in after-market hours amid bullish analyst sentiment.

2026. júl. 20. 23:06 UTC

News

ServiceNow Inc. shares are trading lower in after-market hours amid bearish sentiment over potential disruptions from generative AI and rising Treasury yields.

2026. júl. 20. 23:06 UTC

News

Pomerantz LLP has filed a class action lawsuit against Lucid Group Inc, alleging securities fraud related to misleading statements about operational capabilities and performance.

2026. júl. 20. 23:06 UTC

News
Social Media

General Electric Co advances in aviation technology with a hybrid-electric flight demonstration and secures an engine deal with Philippine Airlines, shares higher after-market.

2026. júl. 20. 23:06 UTC

News

Geopolitical tensions, particularly between the U.S. and Iran, have impacted global consumer sentiment. Nike shares were little changed during after-market hours.

2026. júl. 20. 23:06 UTC

News

Yum Brands Inc shares declined after a report of reduced foot traffic at Taco Bell due to a parasite outbreak linked to lettuce supplied by a vendor.

2026. júl. 20. 23:02 UTC

News

Zions Bancorporation NA reported Q2 earnings of $452 million, or $3.05 per share, but shares are lower in after-market trading amid mixed results.

2026. júl. 20. 23:02 UTC

News

W. R. Berkley Corporation reported strong second-quarter earnings but missed revenue expectations. Shares declined during after-market hours amid notable volatility.

2026. júl. 20. 23:01 UTC

News

Coca-Cola Consolidated Inc shares rose during after-market hours, reflecting positive sentiment in the beverage sector despite earlier session volatility.

2026. júl. 20. 23:01 UTC

News

Karyopharm Therapeutics shares fell in after-market hours following the announcement of a leadership cash retention program aimed at key executives.

2026. júl. 20. 23:01 UTC

Social Media
News

Park Aerospace Corp reported first-quarter earnings of $0.17 per share, exceeding estimates, and is trading higher in after-market hours.

2026. júl. 20. 23:01 UTC

News
Event

Cracker Barrel completed a sale-leaseback for 26 locations, generating $77 million. Shares are trading higher after exceeding previous revenue guidance.

2026. júl. 20. 23:01 UTC

News
Social Media
Event

Crown Holdings reported second-quarter adjusted EPS of $2.49, exceeding estimates. The company raised its full-year EPS guidance, with shares higher in after-market hours.

Társak összehasonlítása

Árváltozás

Heron Therapeutics Inc Előrejelzés

Célár

By TipRanks

316.67% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 2 USD  316.67%

Magas 2 USD

Alacsony 2 USD

2 Wall Street elemző 12 hónapos célárain alapulva a(z)Heron Therapeutics Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

2 ratings

1

Vétel

1

Tartás

0

Eladás

Hangulat

By Acuity

285 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bearish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
help-icon Live chat